This contract expires in 272 days (Jan 14, 2027).
FIRM FIXED PRICE
UTAH STATE UNIVERSITY - B27 - IN VITRO SCREENING MPOX AND ECTROMELIA VIRUSES
PIID: 75N93026F00002
Signed Date: Jan 20, 2026Effective Date: Jan 15, 2019End Date: Closes in 272 days
Key Details
Description
B27 - IN VITRO SCREENING MPOX AND ECTROMELIA VIRUSES
Contractor Information
Similar Awards
CLINICAL SERVICES NETWORK- CLINICAL TRIAL PLANNING AND EXECUTION
ALLUCENT GOVERNMENT SERVICES (US) LLC
$370.1M
CLINICAL SERVICES NETWORK- CLINICAL TRIAL PLANNING AND EXECUTION
ICON GOVERNMENT AND PUBLIC HEALTH SOLUTIONS, INC.
$330.2M
CLINICAL SERVICES NETWORK- CLINICAL TRIAL PLANNING AND EXECUTION
TECHNICAL RESOURCES INTERNATIONAL, INC.
$317.1M
ANTIBIOTIC FOR TREATMENT OF A BIOTHREAT INDICATION
PARATEK PHARMACEUTICALS, INC
$265.3M
ASPR-18-04963 -- FUNDING FOR BALOXAVIR MARBOXIL ACTIVITIES FOR BASE PERIOD TASK UNDER THE GENENTECH OTA
GENENTECH INC
$243.7M
Stay Updated
Get notified about new opportunities matching your interests.